Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study

Bengt Fellström,Hallvard Holdaas,Alan G. Jardine,Helen Rose,Roland E. Schmieder,Wim Wilpshaar,Faiez Zannad

Effect of Rosuvastatin on Outcomes in Chronic Haemodialysis Patients: Baseline Data from the AURORA Study

2007

Bengt Fellström
Hallvard Holdaas
Alan G. Jardine
Helen Rose
Roland E. Schmieder
Wim Wilpshaar
Faiez Zannad

Background: Cardiovascular disease (CVD) is the leading cause of death in patients with end-stage renal disease (ESRD). Aims: AURORA (A study to evaluate the Use

Keywords:

Endocrinology
Cause of death
Rosuvastatin
Internal medicine
Disease
Diabetes mellitus
Medicine
chronic hemodialysis
in patient
end stage renal disease
baseline data

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations